Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
80,562,329
-
Shares change
-
-426,539
-
Total reported value, excl. options
-
$1,594,701,243
-
Value change
-
-$8,205,377
-
Put/Call ratio
-
80.98%
-
Number of buys
-
83
-
Number of sells
-
-107
-
Price
-
$19.8
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q4 2021
240 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q4 2021.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80,562,329 shares
of 105,863,294 outstanding shares and own 76.1% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15,047,993 shares), VANGUARD GROUP INC (10,797,477 shares), RENAISSANCE TECHNOLOGIES LLC (8,023,616 shares), INGALLS & SNYDER LLC (6,737,898 shares), FEDERATED HERMES, INC. (4,625,849 shares), MILLENNIUM MANAGEMENT LLC (3,333,135 shares), STATE STREET CORP (3,308,480 shares), DIMENSIONAL FUND ADVISORS LP (1,883,466 shares), Parallel Advisors, LLC (1,803,382 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,730,872 shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.